CBD Reduced Depression-Like Behavior in Mice by Repairing Cellular Power Plants

Animal study using male C57BL/6 mice. Depression-like behaviors induced by LPS injection. CBD administered intragastrically (70 or 140 mg/kg/day) for 6 days. Outcomes: behavioral tests (depression-like behaviors), hippocampal synaptic health, ROS production, oxidative stress markers, superoxide dismutase activity, mitochondrial biogenesis, mitophagy markers, neuroinflammatory activation markers.

Depression treatment needs new approaches — about 30% of patients don't respond to existing antidepressants. The mitochondrial mechanism identified here is particularly interesting because mitochondrial dysfunction has been increasingly recognized as a feature of depression in humans. If CBD can restore mitochondrial function in the brain, it represents a fundamentally different therapeutic pathway from conventional antidepressants that target neurotransmitters.

This mitochondrial mechanism connects CBD's antidepressant potential to the broader anti-inflammatory and antioxidant pathways documented in the gut review (RTHC-00258) — the Nrf2 pathway that CBD activates in the gut also regulates mitochondrial function. The mental health scoping review (RTHC-00235) noted thin clinical evidence for cannabis and depression; this preclinical study identifies a specific mechanism that could guide future clinical trials. The Kaiser adolescent study (RTHC-00289) found cannabis use associated with depression diagnosis — an important distinction since recreational cannabis (THC-dominant) and isolated CBD may have opposite effects on depression.

Animal model — LPS-induced inflammation is a simplified model of depression that doesn't capture the full complexity of human depressive disorders. CBD doses (70–140 mg/kg) are very high relative to typical human doses. Six-day treatment is short and doesn't address chronic depression. Male mice only — sex differences in depression mechanisms are well-established. The route of depression matters: inflammation-driven depression may respond differently to CBD than other depression subtypes.